Back to Conference Homepage
Back to Conference Faculty List
Back to Conference Schedule
Presentation: Epidemiology of Lung Cancer in Southern California
CLICK HERE to see the PowerPoint presentation
Time: Friday Morning
Purpose: To increase the awareness of lung cancer in Asians and to introduce novel therapies available and to decrease the stigma of a lung cancer diagnosis
Objectives: Describe Epidemiology of lung cancer in Asians in Southern California
Identify novel therapies available for lung cancer patients especially Asian patients
Discuss how to reduce the stigma of a lung cancer diagnosis
Presentation: East Meets West: A 2010 Update on Nasopharyngeal Carcinoma
CLICK HERE to see the PowerPoint presentation
Time: Friday Afternoon
Purpose: To provide a comprehensive update on nasopharyngeal carcinoma (NPC) and compare and contrast different treatments for NPC between Asia and the United States.
Objectives:
Discuss the epidemiology and pathogenesis of NPC
Discuss the management of NPC (pre-treatment work-up, sequencing strategy of chemotherapy and radiation, post-treatment follow-up)
Compare and contrast differences in treatment strategies between east and west and what to learn from the east.
Associate Clinical Professor
Adjunct Assistant Professor of Epidemiology, UCI School of Medicine
Bio:
Sai-Hong Ignatius Ou (吴 世 康) MD PhD is an Associate Clinical Professor in Hematology–Oncology at the Chao Family Comprehensive Cancer Center, University of California Irvine. He specializes in treating upper aerodigestive tract malignancies (Lung, Head and Neck, Thyroid, Esophageal, and Stomach cancer). He received his BA from the University of California Berkeley, his MD and PhD degrees from the University of Texas Southwestern Medical School in Dallas, his medicine residency training at Duke University Medical Center, and his hematology-oncology fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston. His research is focus on the epidemiology on the ethnic differences in lung cancer especially among never-smokers and other upper aerodigestive malignancies and is involved in active collaborations with other cancer registries in Asia. He is also involved in many clinical trials involving novel targeted therapies in lung cancer especially NSCLC with ALK translocation. He is also the Institutional Principal Investigator of the Southwest Oncology Group (SWOG) at UC Irvine.